Back to FMR LLC FMR LLC

LGNDLGND
Showing 8 of 28 quarters

Position history for FMR LLCFMR LLC's holdings in LIGAND PHARMACEUTICALS INC

Yes. FMR holds 762,827 shares of LGND (Ligand Pharmaceuticals), worth $241.1M, as of its Q2 2026 13F filing. It increased the position by 166,700 shares (+28.0%) from Q1 2026. FMR has held LGND in every 13F on record since Q3 2019, 28 quarterly filings.

Current Value

$241.1M

Current Shares

762,827

Total Value Change

+$239.8M

Total Shares Change

+750,078

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
762,827
+28.0%
$241.1M0.0%$316.09
38
2026-Q1
Increased
596,127
+2.9%
$119M0.0%$199.65
31
2025-Q4
Increased
579,155
+26.7%
$109.5M0.0%$189.07
37
2025-Q3
Increased
457,231
+1643.6%
$81M0.0%$177.14
48
2025-Q2
Increased
26,223
+5.2%
$3M0.0%$113.68
28
2025-Q1
Increased
24,933
+32.4%
$2.6M0.0%$105.14
33
2024-Q4
Increased
18,831
+47.7%
$2M0.0%$107.15
36
2024-Q3
Increased
12,749
+550.5%
$1.3M0.0%$100.09
41

Other major holders of LGND: BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used